View Filing Data

Print Document View Excel Document

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Mar. 31, 2016	May 01, 2016
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3
Entity Registrant Name	SolarEdge Technologies Inc
Entity Central Index Key	0001419612
Current Fiscal Year End Date	--06-30
Entity Current Reporting Status	No
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		40,730,849

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2016	Jun. 30, 2015
CURRENT ASSETS:
Cash and cash equivalents	$ 84,070	$ 144,750
Restricted cash	944	3,639
Marketable Securities	44,059
Trade receivables, net	56,145	35,428
Prepaid expenses and other accounts receivable	18,613	32,645
Inventories	85,514	73,950
Total current assets	289,345	290,412
PROPERTY AND EQUIPMENT, NET	26,213	14,717
LONG-TERM ASSETS:
Long-term marketable securities	43,151
Long-term prepaid expenses and lease deposits	440	529
Deferred tax assets, net	6,486
Intangible assets, net	737
Total long-term assets	50,814	529
Total assets	366,372	305,658
CURRENT LIABILITIES:
Trade payables	45,138	80,684
Employees and payroll accruals	12,358	6,814
Warranty obligations	13,510	9,431
Deferred revenues	2,642	1,676
Accrued expenses and other accounts payable	7,797	6,987
Total current liabilities	81,445	105,592
LONG-TERM LIABILITIES
Warranty obligations	33,149	22,448
Deferred revenues	13,266	8,289
Lease incentive obligation	2,265	2,385
Total long-term liabilities	48,680	33,122
Share capital
Common stock of $0.0001 par value - Authorized: 125,000,000 shares as of March 31, 2016 (unaudited) and June 30, 2015; issued and outstanding: 40,684,496 and 39,297,539 shares as of March 31, 2016 (unaudited) and June 30, 2015, respectively.	4	4
Additional paid-in capital	296,480	287,152
Accumulated other comprehensive income (loss)	417	(222)
Accumulated deficit	(60,654)	(119,990)
Total stockholders' equity	236,247	166,944
Total liabilities and stockholders' equity	$ 366,372	$ 305,658

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2016	Jun. 30, 2015
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, authorized shares	125,000,000	125,000,000
Common stock, issued shares	40,684,496	39,297,539
Common stock, outstanding shares	40,684,496	39,297,539

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Revenues	$ 125,205	$ 86,399	$ 365,091	$ 226,658
Cost of revenues	84,471	62,698	252,248	173,146
Gross profit	40,734	23,701	112,843	53,512
Operating expenses:
Research and development, net	8,709	5,490	23,999	15,317
Sales and marketing	8,826	6,422	25,903	17,541
General and administrative	3,460	1,990	9,066	4,270
Total operating expenses	20,995	13,902	58,968	37,128
Operating income	19,739	9,799	53,875	16,384
Financial income (expenses), net	2,029	(3,436)	998	(3,378)
Income before taxes on income	21,768	6,363	54,873	13,006
Taxes on income (tax benefit)	969	398	(4,463)	1,146
Net income	$ 20,799	$ 5,965	$ 59,336	$ 11,860
Net basic earnings per share of common stock	$ 0.52	$ 0.01	$ 1.49	$ 0.02
Net diluted earnings per share of common stock	$ 0.47	$ 0.01	$ 1.34	$ 0.01
Weighted average number of shares used in computing net basic earnings per share of common stock	40,362,093	2,822,893	39,725,227	2,817,090
Weighted average number of shares used in computing net diluted earnings per share of common stock	44,577,901	7,099,046	44,347,071	5,534,903

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Statement of Comprehensive Income [Abstract]
Net income	$ 20,799	$ 5,965	$ 59,336	$ 11,860
Available-for-sale securities:
Changes in unrealized losses, net of tax benefit	87		6
Reclassification adjustments for losses included in net income	1		1
Net change	88		7
Cash flow hedges:
Changes in unrealized gains, net of tax expense	668		745
Reclassification adjustments for gains, net of tax expense included in net income	(33)		(35)
Net change	635		710
Foreign currency translation adjustments, net	(13)	(102)	(78)	(202)
Other comprehensive income (loss)	710	(102)	639	(202)
Comprehensive income	$ 21,509	$ 5,863	$ 59,975	$ 11,658

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows provided by (used in) operating activities:
Net income	$ 59,336	$ 11,860
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	2,601	1,647
Amortization of intangible assets	63
Amortization of premiums on available-for-sale marketable securities	209
Stock-based compensation related to employees and non-employees consultants stock options	6,689	1,750
Financial income, net related to term loan		(992)
Remeasurement of warrants to purchase preferred and common stock		2,065
Changes in assets and liabilities:
Inventories	(11,446)	(39,071)
Prepaid expenses and other accounts receivable	13,186	(12,198)
Trade receivables, net	(20,681)	(25,993)
Deferred tax assets, net	(6,627)
Trade payables	(35,554)	39,604
Employees and payroll accruals	5,517	883
Warranty obligations	14,780	9,718
Deferred revenues	5,942	2,116
Accrued expenses and other accounts payable	497	2,733
Lease incentive obligation	(120)	2,243
Net cash provided by (used in) operating activities	34,392	(3,635)
Cash flows used in investing activities:
Purchase of property and equipment	(11,545)	(8,254)
Purchase of intangible assets	(800)
Decrease (increase) in restricted cash	2,695	(1,973)
Decrease (increase) in short and long-term lease deposits	23	(24)
Purchases of available-for-sale marketable securities	(88,883)
Maturities of available-for-sale marketable securities	1,000
Net cash used in investing activities	(97,510)	(10,251)
Cash flows from financing activities:
Proceeds from short-term bank loans		23,000
Repayments of short-term loan		(36,326)
Repayments of term loan		(5,919)
Proceeds from issuance of stock		24,712
Proceeds from IPO, net		133,944
Proceeds from exercise of employees and non-employees consultants stock options	2,639	46
Net cash provided by financing activities	2,639	139,457
Increase (decrease) in cash and cash equivalents	(60,479)	125,571
Cash and cash equivalents at the beginning of the period	144,750	9,754
Erosion due to exchange rate differences	(201)	(121)
Cash and cash equivalents at the end of the period	84,070	135,204
Supplemental disclosure of non-cash financing activities:
Issuance expenses not paid in cash		$ 2,489

GENERAL

9 Months Ended

Mar. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GENERAL

NOTE 1:-

GENERAL

SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) and (iii) a related cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters of a solar PV system to enable customers and system owners, as applicable, to monitor and manage the solar PV systems. The Company operates its business itself and through its wholly-owned subsidiaries: SolarEdge Technologies Ltd. in Israel; SolarEdge Technologies GmbH in Germany; SolarEdge Technologies (China) Co., Ltd in China; SolarEdge Technologies (Australia) PTY Ltd. in Australia; SolarEdge Technologies (Canada) Ltd. in Canada; SolarEdge Technologies (Holland) B.V. in the Netherlands; SolarEdge Technologies (UK) Ltd in United Kingdom; SolarEdge Technologies (Japan) Co., Ltd. in Japan, SolarEdge Technologies (France) SARL in France, SolarEdge Technologies Italy S.R.L. in Italy and SolarEdge Technologies (Bulgaria) Ltd. in Bulgaria (collectively, the “subsidiaries”). Except for SolarEdge Technologies Ltd in Israel, which carries out the research and development, management of manufacturing, global sales and support and management activities, the other subsidiaries are engaged solely in selling, marketing and support activities. The Company was incorporated in Delaware in August 2006 and began commercial sale of its products in January 2010.

Recent accounting pronouncements:

Inventory:

In July 2015, the Financial Accounting Standards Board (“FASB”) issued “ASU 2015-11, Inventory (Topic 330), simplifying the Measurement of Inventory”, which changes the measurement principles for inventory from the lower of cost or market to the lower of cost and net realizable value. Net realizable value is defined as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.” ASU 2015-11 eliminates the guidance that required entities to consider replacement cost or net realizable value less an approximately normal profit margin in the subsequent measurement of inventory when cost is determined on a first-in, first-out or average cost basis. The provisions of ASU 2015-11 are effective for public entities with fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted. The Company is in the process of evaluating the impact of ASU 2015-11 on its consolidated financial position, consolidated results of operations, and consolidated cash flows

Deferred Taxes:

In November 2015, the FASB issued ASU 2015-17, Income Taxes (Topic 740) - Balance Sheet Classification of Deferred Taxes, which will require that the presentation of deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. The Company has adopted this guidance effective December 31, 2015. The adoption only impacted the presentation in its consolidated financial statements and related disclosure. No prior periods were retroactively adjusted.

The significant accounting policies applied in the Company’s audited annual consolidated financial statements as of June 30, 2015 are applied consistently in these financial statements.

Basis of Presentation:

The accompanying unaudited consolidated interim financial statements have been prepared in accordance with Article 10 of Regulation S-X, “Interim Financial Statements” and the rules and regulations for Form 10-Q of the Securities and Exchange Commission (the “SEC”). Pursuant to those rules and regulations, the Company has condensed or omitted certain information and footnote disclosure it normally includes in its annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). In management’s opinion, the Company has made all adjustments (consisting only of normal, recurring adjustments, except as otherwise indicated) necessary to fairly present its consolidated financial position, results of operations and cash flows. The Company’s interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the 2015 consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for its fiscal year ended June 30, 2015 filed with the SEC on August 20, 2015 (the “2015 Form 10-K”). There have been no changes in the significant accounting policies from those that were disclosed in the audited consolidated financial statements for the fiscal year ended June 30, 2015 included in the 2015 Form 10-K.

The Company depends on two contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields and costs.

Two vendors collectively account for 72% (unaudited) and 79% of the Company’s total trade payables as of March 31, 2016 (unaudited) and June 30, 2015, respectively.

Marketable Securities:

Marketable securities consist of corporate and governmental bonds. The Company determines the appropriate classification of marketable securities at the time of purchase and re-evaluates such designation at each balance sheet date. In accordance with FASB ASC No. 320 “Investments- Debt and Equity Securities”, the Company classifies marketable securities as available-for-sale. Available-for-sale securities are stated at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), a separate component of stockholders’ equity, net of taxes. Realized gains and losses on sales of marketable securities, as determined on a specific identification basis, are included in financial income (expenses), net. The amortized cost of marketable securities is adjusted for amortization of premium and accretion of discount to maturity, both of which, together with interest, are included in financial income (expenses), net. The Company classifies its marketable debt securities as either short-term or long-term based on each instrument’s underlying contractual maturity date. Marketable debt securities with maturities of 12 months or less are classified as short-term and marketable debt securities with maturities greater than 12 months are classified as long-term.

The Company recognizes an impairment charge when a decline in the fair value of its investments in debt securities below the cost basis of such securities is judged to be other-than-temporary. Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and the Company’s intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. If the Company does not intend to sell the security or it is not more likely than not that it will be required to sell the security before it recovers in value, the Company must estimate the net present value of cash flows expected to be collected. If the amortized cost exceeds the net present value of cash flows, such excess is considered a credit loss and an other-than-temporary impairment has occurred. For securities that are deemed other-than-temporarily impaired (“OTTI”), the amount of impairment is recognized in the statement of operations and is limited to the amount related to credit losses, while impairment related to other factors is recognized in other comprehensive income (loss). The Company did not recognize OTTI on its marketable securities during the nine months ended on March 31, 2016.

Derivative financial instruments:

The Company accounts for derivatives and hedging based on ASC 815 (“Derivatives and Hedging”). ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship.

To protect against the increase in value of forecasted foreign currency cash flows resulting from salary and lease payments of its Israeli facilities denominated in the Israeli currency, the New Israeli Shekel (“NIS”), during the three and nine months ended March 31, 2016, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll and lease payments denominated in NIS for a period of one to twelve months with hedging contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the hedging contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency cash flows is offset by gains in the fair value of the hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges of these expenses.

In accordance with ASC 815, for derivative instruments that are designated and qualify as a cash flow hedge (i.e. hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Any gain or loss on a derivative instrument in excess of the cumulative change in the present value of future cash flows of the hedged item is recognized in current earnings during the period of change.

In addition to the above mentioned cash flow hedges transactions, the Company also entered into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the U.S. dollar. These derivative instruments are not designated as cash flows hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of operations, as financial income (expenses).

As of March 31, 2016, the Company entered into forward contracts and put and call options to sell U.S. dollars and Euros in the amount of $19,547 and €2,500,000, respectively. These hedging contracts do not contain any credit-risk-related contingency features. See Note 6 for information on the fair value of these hedging contracts.

The fair value of derivative assets and derivative liabilities as of March 31, 2016 was $854 and $5, respectively which was recorded in other accounts receivable and prepaid expenses in the consolidated balance sheets.

The amount recorded as gain in the cost of revenues expenses under the consolidated statements of operations for the three and the nine months ended March 31, 2016 (unaudited) resulted from the above referenced hedging transactions was $8.

The amount recorded as gain in the research and development, net expenses under the consolidated statements of operations for the three and the nine months ended March 31, 2016 (unaudited) resulted from the above referenced hedging transactions was $18.

The amount recorded as gain in the sales and marketing expenses under the consolidated statements of operations for the three and the nine months ended March 31, 2016 (unaudited) resulted from the above referenced hedging transactions was $11.

The amount recorded as gain in the general and administrative expenses under the consolidated statements of operations for the three and the nine months ended March 31, 2016 (unaudited) resulted from the above referenced hedging transactions was $3 and $6, respectively.

The fair value of the outstanding derivative instruments as of March 31, 2016 (unaudited) and June 30, 2015 is summarized below:

		Fair Value of Derivative Instruments
	Balance Sheet Location	As of March 31, 2016 (unaudited)		As of June 30, 2015
Derivative Assets
Foreign exchange forward contracts and put and call options	Prepaid expenses and other accounts receivable (*)		849		859

Total			849		859

(*) Estimated to be reclassified into earnings until December 31, 2016.

The effect of derivative instruments in cash flow hedging transactions on income and other comprehensive income (“OCI”) for the three and the nine months ended March 31, 2016 and 2015 is summarized below:

Gains on Derivatives Recognized in
OCI

for the three months ended

for the nine months ended

March 31,

2016

2015

2016

2015

(unaudited)

Foreign exchange

forward contracts

and put and call

options

668

745

Gains Reclassified from OCI into
Income

for the three months ended

for the nine months ended

March 31,

2016

2015

2016

2015

(unaudited)

Foreign exchange

forward contracts

and put and call

options

Intangible assets:

On March 9, 2015, the Company and Beacon Power LLC, a Delaware limited liability company (“Beacon”) entered into a patent purchase agreement under which the Company agreed to purchase all rights in the patents. In July 2015, the Company completed the purchase of the patents for $800.

The patents are stated at cost, net of accumulated amortization. Amortization is calculated by the straight-line method over 10 years, which represents the estimated useful lives of the patents.

Amortization expenses for the three and the nine months ended March 31, 2016 (unaudited) were $21 and $63, respectively.

Accumulated other comprehensive income (loss):

The following table summarizes the changes in accumulated balances of other comprehensive income (loss), net of taxes, for the three months ended March 31, 2016 (unaudited):

	Unrealized gains (losses) on available-for-sale marketable securities			Unrealized gains (losses) on cash flow hedges			Unrealized gains (losses) on foreign currency translation			Total

Beginning balance		(81	)		75			(287	)		(293	)
Other comprehensive income (loss) before reclassifications		87			668			(13	)		742
Losses (gains) reclassified from accumulated other comprehensive income (loss)		1			(33	)		-			(32	)
Net current period other comprehensive income (loss)		88			635			(13	)		710

Ending balance		7			710			(300	)		417

The following table summarizes the changes in accumulated balances of other comprehensive loss, net of taxes, for the nine months ended March 31, 2016 (unaudited):

	Unrealized gains (losses) on available-for-sale marketable securities		Unrealized gains (losses) on cash flow hedges			Unrealized gains (losses) on foreign currency translation			Total

Beginning balance		-		-			(222	)		(222	)
Other comprehensive income (loss) before reclassifications		6		745			(78	)		673
Losses (gains) reclassified from accumulated other comprehensive income (loss)		1		(35	)		-			(34	)
Net current period other comprehensive income (loss)		7		710			(78	)		639

Ending balance		7		710			(300	)		417

MARKETABLE SECURITIES

9 Months Ended

Mar. 31, 2016

Investments, Debt and Equity Securities [Abstract]

MARKETABLE SECURITIES

NOTE 2:-

MARKETABLE SECURITIES

The following is a summary of available-for-sale marketable securities at March 31, 2016 (unaudited):

	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value

Corporate bonds	$	82,183	$	55	$	36	$	82,202
Governmental bonds	$	5,015	$	3	$	10	$	5,008

	$	87,198	$	58	$	46	$	87,210

As of June 30, 2015, the Company had no investments in marketable securities.

The amortized cost of available-for-sale marketable securities at March 31, 2016, by contractual maturities, is shown below:

	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value

Due in one year or less	$	44,050	$	21	$	12	$	44,059
Due after one year to two years	$	43,148	$	37	$	34	$	43,151

	$	87,198	$	58	$	46	$	87,210

As of March 31, 2016, management believes the impairments are not other than temporary and therefore the impairment losses were recorded in accumulated other comprehensive income (loss). The Company has no intent to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to the recovery of the entire amortized cost basis.

As of March 31, 2016 (unaudited), there was 32 securities in a loss position.

The total fair value of marketable securities with outstanding unrealized losses as of March 31, 2016 (unaudited) amounted to $40,147, while the unrealized losses for these marketable securities amounted to $46.

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References + Details

INVENTORIES

9 Months Ended

Mar. 31, 2016

Inventory Disclosure [Abstract]

INVENTORIES

NOTE 3:-

INVENTORIES

	March 31, 2016		June 30, 2015
	(unaudited)

Raw materials	$	10,639	$	14,405
Finished goods		74,875		59,545

	$	85,514	$	73,950

WARRANTY OBLIGATIONS

9 Months Ended

Mar. 31, 2016

Product Warranties Disclosures [Abstract]

WARRANTY OBLIGATIONS

NOTE 4:-

WARRANTY OBLIGATIONS

Changes in the Company’s product warranty liability for the nine months ended March 31, 2016 and 2015 were as follows:

	Nine months ended March 31,
	2016			2015
	(unaudited)

Balance, at beginning of period	$	31,879		$	18,181
Additions and adjustments to cost of revenues		21,250			13,456
Usage and current warranty expenses		(6,470	)		(3,738	)

Balance, at end of period		46,659			27,899
Less current portion		13,510			7,661

Long term portion	$	33,149		$	20,238

REVOLVING CREDIT LINE

9 Months Ended

Mar. 31, 2016

Line of Credit Facility [Abstract]

REVOLVING CREDIT LINE

NOTE 5:-

REVOLVING CREDIT LINE

In June 2011, the Company entered into an agreement for a revolving line of credit from a bank lender (the "Bank Lender").

On February 17, 2015, the Company amended and restated the agreement with the Bank Lender for its revolving line of credit, which permits aggregate borrowings of up to $40 million in an amount not to exceed 80% of the eligible accounts receivable and bears interest, payable monthly, at the Bank Lender’s prime rate plus a margin of 0.5% to 2.0%. The Company’s revolving line of credit will terminate, and outstanding borrowings will be payable, on December 31, 2016.

In connection with the revolving line of credit, the Company granted the Bank Lender security interests in substantially all of the Company’s assets, including a first-priority security interest in the Company’s trade receivables, cash and cash equivalents. Financial covenants contained in the amended and restated agreement require the Company to maintain EBITDA and liquidity at specified levels.

The Company is required to maintain liquidity (defined as unrestricted and unencumbered cash, plus availability in the amended and restated agreement) of $6,750.

The amended and restated agreement also contains covenants that restrict the Company’s ability to dispose of assets, engage in business combinations (or permit a subsidiary to engage in business combinations), grant liens, borrow money, or pay dividends.

As of March 31, 2016 (unaudited) and June 30, 2015, the Company was in compliance with all applicable covenants in the amended and restated agreement.

As of March 31, 2016 (unaudited), the Company had no outstanding borrowings pursuant to this revolving line of credit.

FAIR VALUE MEASUREMENTS

9 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 6:-

FAIR VALUE MEASUREMENTS

The Company evaluates assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level to classify them for each reporting period. There have been no transfers between fair value measurements levels during the nine months ended March 31, 2016.

The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value:

	Level 1-	Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
	Level 2-	Include other inputs that are directly or indirectly observable in the marketplace.

Level 3-

Unobservable inputs which are supported by little or no market activity.

The following table sets forth the Company’s assets that were measured at fair value as of March 31, 2016 (unaudited) by level within the fair value hierarchy:

	Balance as of		Fair value measurements
Description	March 31, 2016 (unaudited)		Level 1		Level 2		Level 3

Cash equivalents:
Money market mutual funds	$	17,520	$	17,520		-		-

Derivative instruments asset	$	849		-	$	849		-

Short-term marketable securities:
Corporate bonds	$	43,055		-	$	43,055		-
Governmental bonds	$	1,004		-	$	1,004		-

Long-term marketable securities:
Corporate bonds	$	39,147		-	$	39,147		-
Governmental bonds	$	4,004		-	$	4,004		-

The following table sets forth the Company’s assets that were measured at fair value as of June 30, 2015 by level within the fair value hierarchy:

	Balance as of		Fair value measurements
Description	June 30, 2015		Level 1		Level 2		Level 3

Derivative instruments asset	$	859		-	$	859		-

In addition to the assets described above, the Company’s financial instruments also include cash and cash equivalents, restricted and short-term deposits, trade receivables, other accounts receivable, trade payables, accrued expenses and other payables. The fair value of these financial instruments was not materially different from their carrying values on Mach 31, 2016 due to the short-term maturity of these instruments.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

LEASE INCENTIVE OBLIGATION

9 Months Ended

Mar. 31, 2016

Leases [Abstract]

LEASE INCENTIVE OBLIGATION

NOTE 7:-

LEASE INCENTIVE OBLIGATION

The Company has an operating lease agreement for a building in Herziliya, Israel. In connection with this lease, the Company and its third party lessor (the "Lessor"), agreed that the Lessor would reimburse approximately $2,938 for certain leasehold improvements made by the Company.

As of March 31, 2016 (unaudited), the Company received in cash $2,917 from the Lessor in connection with such leasehold improvements. These leasehold improvements are accounted for as a lease incentive obligation, which is recorded under long-term liabilities, net of the current portion recorded in accrued expenses and other accounts payable under current liabilities. The lease incentive obligation is being amortized over the life of the lease and as a reduction to rent expense. As of March 31, 2016, the net amortized amount of lease incentive obligation recorded under long-term liabilities is $2,265.

COMMITMENTS AND CONTINGENT LIABILITIES

9 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENT LIABILITIES

NOTE 8:-

COMMITMENTS AND CONTINGENT LIABILITIES

Lease commitments:

The Company and its subsidiaries lease their operating facilities under non-cancelable operating lease agreements, which expire over the next nine years, with the last ending in December 2024.

The future minimum lease commitments of the Company and its subsidiaries under various non-cancelable operating lease agreements in respect of premises that are in effect as of March 31, 2016 (unaudited), are as follows:

Year ended June 30,	(unaudited)

2016		598
2017		2,252
2018		2,148
2019		2,003
2020 and thereafter		8,707

		15,708

Rent expenses for the nine months ended March 31, 2016 (unaudited) and 2015 (unaudited) were approximately $1,653 and $1,222, respectively.

Guarantees:

As of March 31, 2016 (unaudited), contingent liabilities exist regarding guarantees in the amount of $631, $53 and $85 in respect of office rent lease agreements, customs transactions and credit card limits, respectively.

Royalty and Governmental commitments:

As of March 31, 2016 (unaudited), the aggregate contingent liability to the Binational Industrial Research and Development Foundation (BIRD-F) amounted to approximately $1,132 which would be payable by the Company if it ever did generate revenues from such project.

As of March 31, 2016 (unaudited), the aggregate contingent liability to the Office of the Chief Scientist (the OCS) amounted to $782.

Contractual purchase obligations:

The Company has contractual obligations to purchase certain goods and raw materials. These contractual purchase obligations relate to certain inventories held by contract manufacturers and purchase orders initiated by the contract manufacturers and suppliers, which cannot be canceled without penalty. The Company utilizes third parties to manufacture its products. In addition, it acquires raw materials or other goods and services, including product components, by issuing to suppliers authorizations to purchase based on its projected demand and manufacturing needs. As of March 31, 2016 (unaudited), the Company had non-cancelable purchase obligations totaling approximately $84,275, of which the Company already recorded a provision for loss in the amount of $1,860.

Legal claims:

From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular matter.

STOCK CAPITAL

9 Months Ended

Mar. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK CAPITAL

NOTE 9:-

STOCK CAPITAL

On March 23, 2015, the Company's board of directors and the requisite holders of the Company's capital stock consented to a 1-for-3 reverse stock split of the Company's common stock. As a result of the reverse stock split, (i) every 3 shares of authorized, issued and outstanding common stock was decreased to one share of authorized, issued and outstanding common stock, (ii) the number of shares of common stock into which each outstanding warrant or option to purchase common stock is exercisable was proportionally decreased on a 1-for-3 basis, (iii) all share prices and exercise prices were proportionately increased. All of the share numbers, share prices, and exercise prices have been adjusted within these consolidated financial statements, on a retroactive basis, to reflect this 1-for-3 reverse stock split.

Common Stock:

Authorized

Issued and outstanding

Number of shares

March 31, 2016

June 30,

2015

March 31, 2016

June 30,

2015

(unaudited)

Stock of $0.0001 par value:

Common stock

125,000,000

40,684,496

39,297,539

Stock Incentive plans:

The Company’s 2007 Global Incentive Plan (the “2007 Plan”) was adopted by the board of directors on August 30, 2007. On March 31, 2015, upon consummation of the Company’s Initial Public Offering (“IPO”), the 2007 Plan was terminated and no further awards will be granted thereunder. All outstanding awards will continue to be governed by their existing terms and 379,358 available options for future grant were transferred to the Company’s 2015 Global Incentive Plan (the “2015 Plan”) and are reserved for future issuances under the 2015 Plan.

The 2015 Plan became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, RSUs and other share-based awards to directors, employees, officers and consultants of the Company and its subsidiaries. The Share Reserve will automatically increase on January 1st of each year during the term of the 2015 Plan commencing on January 1st of the year following the year in which the 2015 Plan becomes effective in an amount equal to five percent (5%) of the total number of shares of common stock outstanding on December 31st of the preceding calendar year; provided, however, that our board of directors may provide that there will not be a January 1st increase in the Share Reserve in a given year or that the increase will be less than five percent (5%) of the shares of common stock outstanding on the preceding December 31st.

The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is ten million (10,000,000).

As of March 31, 2016 (unaudited), a total of 3,827,117 (unaudited) shares of common stock were reserved for issuance under the 2015 Plan (the “Share Reserve”).

As of March 31, 2016 (unaudited), an aggregate of 2,731,852 shares of common stock are available for future grant under the 2015 Plan.

Options granted to employees and members of the board of directors:

A summary of the activity in the options granted to employees and members of the board of directors for the nine months ended March 31, 2016 (unaudited) and related information follows:

						Weighted
						average
				Weighted		remaining
	Number			average		contractual		Aggregate
	of			exercise		term		intrinsic
	Options			price		in years		value

Outstanding as of July 1, 2015		6,034,782			3.14		7.06		200,438
Granted		228,800			25.09
Exercised		(1,230,923	)		2.05
Forfeited or expired		(46,971	)		3.86
Outstanding as of March 31, 2016		4,985,688			4.41		6.75		103,375

Vested and expected to vest as of March 31, 2016		4,798,492			4.33		6.73		99,877

Exercisable as of March 31, 2016		3,099,118			2.88		5.65		68,974

The aggregate intrinsic value represents the total intrinsic value (the difference between the fair value of the Company’s common stock as of the last day of each period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last day of each period. The total intrinsic value of options exercised during the nine months ended on March 31, 2016 (unaudited) was $27,602.

The weighted average grant date fair values of options granted to employees and executive directors during the nine months ended March 31, 2016 (unaudited) was $25.09.

The options outstanding as of March 31, 2016 (unaudited) have been separated into exercise price ranges as follows:

			Weighted		Options		Weighted
	Outstanding		average		exercisable		average
Range of	as of		remaining		as of		remaining
exercise	March 31,		contractual		March 31,		contractual
price	2016		life in years		2016		life in years

$0.87 - $1.50		770,940		2.89		770,940		2.89
$1.68 - $2.46		1,465,040		5.49		1,408,292		5.46
$3.03 - $3.96		542,018		7.53		279,270		7.24
$5.01		1,945,562		8.66		602,296		8.66
$9.36		33,328		8.84		9,720		8.84
$25.09		228,800		9.39		28,600		9.39

		4,985,688		6.75		3,099,118		5.65

A summary of the activity in the RSUs granted to employees and members of the board of directors for the nine months ended March 31, 2016 (unaudited), is as follows:

	No. of Options			Weighted average grant date fair value
Unvested as of July 1, 2015		67,440			25.09
Granted		807,656			24.45
Vested		(112,591	)		24.57
Forfeited		(40,965	)		24.07
Unvested as of March 31, 2016		721,540			24.38

Options and RSUs issued to non-employee consultants:

The Company has granted options and RSUs to non-employee consultants as of March 31, 2016 (unaudited) as follows:

	Outstanding				Exercisable
	as of				as of
Issuance	March 31,		Exercise		March 31,		Exercisable
date	2016		price		2016		through

July 31, 2008		33,333		0.87		33,333	July 31, 2018
October 24, 2012		5,166		2.46		4,333	October 24, 2022
January 23, 2013		3,333		3.03		2,778	January 23, 2023
January 27, 2014		4,698		3.51		2,226	January 27, 2024
May 1, 2014		6,000		3.51		3,167	May 1, 2024
September 17, 2014		10,830		3.96		4,790	September 17, 2024
October 29, 2014		5,788		5.01		1,010	October 29, 2024
August 19, 2015		28,167		0.00		-
November 8, 2015		4,167		0.00		-

		101,482				51,637

The Company had accounted for its options and RSUs granted to non-employee consultants under the fair value method of ASC 505-50. In connection with the grant of options and RSUs to non-employee consultants, the Company recorded stock compensation expenses in the three months ended March 31, 2016 (unaudited) and 2015 (unaudited) in the amounts $91, and $228, respectively, and stock compensation expenses in the nine months ended March 31, 2016 and 2015 in the amounts $464 and $331, respectively

Stock-based compensation expense for employees and consultants:

The Company recognized stock-based compensation expenses related to options and RSUs granted to employees and non-employees in the consolidated statement of operations for the three and six months ended on March 31, 2016 (unaudited) and 2015 (unaudited), as follows:

	Three months ended March 31,				Nine months ended March 31,
	2016		2015		2016		2015

Cost of revenues	$	246	$	140	$	635	$	254
Research and development		724		183		1,637		449
Selling and marketing		842		292		2,207		545
General and administrative		819		355		2,210		502

Total stock-based compensation expense	$	2,631	$	970	$	6,689	$	1,750

As of March 31, 2016 (unaudited), there was a total unrecognized compensation expense of $26,384 related to non-vested equity-based compensation arrangements granted under the Company’s plans. These expenses are expected to be recognized during the period from April 1, 2016 through February 29, 2020.

INCOME TAXES

9 Months Ended

Mar. 31, 2016

Income Tax Disclosure [Abstract]

INCOME TAXES

NOTE 10:-

INCOME TAXES

Taxes on income (tax benefit) are comprised as follows:

	Three months ended March 31,					Nine months ended March 31,
	2016			2015		2016			2015
	Unaudited					Unaudited

Current year taxes	$	1,069		$	398	$	2,380		$	1,146
Previous year taxes		-			-		(216	)		-
Deferred tax expense (income)		(100	)		-		(6,627	)		-

Taxes on income (tax benefit)	$	969		$	398	$	(4,463	)	$	1,146

Deferred income taxes:

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

Significant components of the Company’s deferred tax liabilities and assets are as follows:

	March 31,		June 30,
	2016		2015
	(Unaudited)

Assets in respect of:

Carryforward tax losses	$	-	$	23,033
Research and Development carryforward expenses- temporary differences		4,488		5,173
Stock-based compensation		548		-
Other reserves		1,450		1,346

		6,486		29,552

Valuation allowance (1)		-		(29,552	)

Net deferred tax assets	$	6,486	$	-

(1)

ASC 740 requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company evaluated the net deferred tax assets for each separate tax entity. As of June 30, 2015, the Company concluded that it is not more likely than not that the net deferred tax assets will be realized and a full valuation allowance has been recorded against these assets. The Company's estimate of future book-taxable income considers available evidence, both positive and negative, about its operating businesses and investments, including an aggregation of individual projections for each significant operating business and investment, estimated apportionment factors for state and local taxing jurisdictions and includes all future years that the Company estimated it would have available net operating loss carryforwards.

During the second fiscal quarter of 2016, the Company determined that the positive evidence outweighs the negative evidence for deferred tax assets and concluded that these deferred tax assets are realizable on a "more likely than not" basis. This determination was mainly due to expected future results of positive operations and earnings history.

BASIC AND DILUTED NET EARNINGS PER SHARE

9 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

BASIC AND DILUTED NET EARNINGS PER SHARE

NOTE 11:-

BASIC AND DILUTED NET EARNINGS PER SHARE

Basic net earnings per share is computed by dividing the net earnings by the weighted-average number of shares of common stock outstanding during the period.

The total weighted average number of shares of common stock related to the outstanding stock options, convertible preferred stock and warrants to purchase convertible preferred stock and common stock, excluded from the calculation of diluted net earnings per share due to their anti-dilutive effect, was 0 and 28,351,707 for the three months ended March 31, 2016 (unaudited) and 2015 (unaudited), respectively and 12,945 and 27,378,784 for the nine months ended March 31, 2016 (unaudited) and 2015 (unaudited), respectively

Basic and diluted earnings per share is presented in conformity with the two-class method for participating securities for the periods prior to their conversion. Under this method, the earnings per share for each class of shares are calculated assuming 100% of the Company's earnings are distributed as dividends to each class of shares based on their contractual rights.

The following table presents the computation of basic and diluted net earnings per share for the periods presented:

	Three months ended March 31,					Nine months ended March 31,
	2016		2015			2016		2015
	(unaudited)					(unaudited)
Numerator:
Net income		20,799		5,965			59,336		11,860
Dividends accumulated for the period		-		(5,923	)		-		(11,817	)
Net income available to holders of common stock		20,799		42			59,336		43

Denominator:
Shares used in computing net earnings per share of common stock, basic		40,362,093		2,822,893			39,725,227		2,817,090

Numerator:
Net income		20,799		5,965			59,336		11,860
Dividends accumulated for the period		-		(5,872	)		-		(11,782	)
Net income available to holders of common stock		20,799		93			59,336		78

Denominator:
Shares used in computing net earnings per share of common stock, diluted		44,577,901		7,099,046			44,347,071		5,534,903

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

9 Months Ended

Mar. 31, 2016

Risks and Uncertainties [Abstract]

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

NOTE 12:-

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

For the three month period ended March 31, 2016 (unaudited), the Company had two major customers that accounted for approximately 26.7% of its consolidated revenues.

For the nine month period ended March 31, 2016 (unaudited), the Company had three major customers that accounted for approximately 34.9% of its consolidated revenues.

For the year ended June 30, 2015, the Company had one major customer that accounted for 24.6% of its consolidated revenues.

As of March 31, 2016 (unaudited), three customers accounted for 38.5% of the Company’s net accounts receivable and as of June 30, 2015, one customer accounted for 30.0% of the Company’s net accounts receivable.

GENERAL (Tables)

9 Months Ended

Mar. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Fair Value of Derivative Instruments

		Fair Value of Derivative Instruments
	Balance Sheet Location	As of March 31, 2016 (unaudited)		As of June 30, 2015
Derivative Assets
Foreign exchange forward contracts and put and call options	Prepaid expenses and other accounts receivable (*)		849		859

Total			849		859

Schedule of Derivative Instruments Gains Recognized in OCI

Gains on Derivatives Recognized in OCI

for the three months ended

for the nine months ended

March 31,

2016

2015

2016

2015

(unaudited)

Foreign exchange

forward contracts

and put and call

options

668

745

Gains Reclassified from OCI into Income

for the three months ended

for the nine months ended

March 31,

2016

2015

2016

2015

(unaudited)

Foreign exchange

forward contracts

and put and call

options

Schedule of Derivative Gains (Losses) Reclassified From OCI Into Income

	Unrealized gains (losses) on available-for-sale marketable securities			Unrealized gains (losses) on cash flow hedges			Unrealized gains (losses) on foreign currency translation			Total

Beginning balance		(81	)		75			(287	)		(293	)
Other comprehensive income (loss) before reclassifications		87			668			(13	)		742
Losses (gains) reclassified from accumulated other comprehensive income (loss)		1			(33	)		-			(32	)
Net current period other comprehensive income (loss)		88			635			(13	)		710

Ending balance		7			710			(300	)		417

The following table summarizes the changes in accumulated balances of other comprehensive loss, net of taxes, for the nine months ended March 31, 2016 (unaudited):

	Unrealized gains (losses) on available-for-sale marketable securities		Unrealized gains (losses) on cash flow hedges			Unrealized gains (losses) on foreign currency translation			Total

Beginning balance		-		-			(222	)		(222	)
Other comprehensive income (loss) before reclassifications		6		745			(78	)		673
Losses (gains) reclassified from accumulated other comprehensive income (loss)		1		(35	)		-			(34	)
Net current period other comprehensive income (loss)		7		710			(78	)		639

Ending balance		7		710			(300	)		417

MARKETABLE SECURITIES (Tables)

9 Months Ended

Mar. 31, 2016

Investments, Debt and Equity Securities [Abstract]

Summary of Available-For-Sale Marketable Securities

	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value

Corporate bonds	$	82,183	$	55	$	36	$	82,202
Governmental bonds	$	5,015	$	3	$	10	$	5,008

	$	87,198	$	58	$	46	$	87,210

Summary of amortized cost of available-for-sale marketable securities

	Amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value

Due in one year or less	$	44,050	$	21	$	12	$	44,059
Due after one year to two years	$	43,148	$	37	$	34	$	43,151

	$	87,198	$	58	$	46	$	87,210

- Definition

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

+ References + Details

INVENTORIES (Tables)

9 Months Ended

Mar. 31, 2016

Inventory Disclosure [Abstract]

Schedule of inventories

	March 31, 2016		June 30, 2015
	(unaudited)

Raw materials	$	10,639	$	14,405
Finished goods		74,875		59,545

	$	85,514	$	73,950

WARRANTY OBLIGATIONS (Tables)

9 Months Ended

Mar. 31, 2016

Product Warranties Disclosures [Abstract]

Schedule of warranty obligations

	Nine months ended March 31,
	2016			2015
	(unaudited)

Balance, at beginning of period	$	31,879		$	18,181
Additions and adjustments to cost of revenues		21,250			13,456
Usage and current warranty expenses		(6,470	)		(3,738	)

Balance, at end of period		46,659			27,899
Less current portion		13,510			7,661

Long term portion	$	33,149		$	20,238

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Schedule of assets and liabilities measured at fair value by level

	Balance as of		Fair value measurements
Description	March 31, 2016 (unaudited)		Level 1		Level 2		Level 3

Cash equivalents:
Money market mutual funds	$	17,520	$	17,520		-		-

Derivative instruments asset	$	849		-	$	849		-

Short-term marketable securities:
Corporate bonds	$	43,055		-	$	43,055		-
Governmental bonds	$	1,004		-	$	1,004		-

Long-term marketable securities:
Corporate bonds	$	39,147		-	$	39,147		-
Governmental bonds	$	4,004		-	$	4,004		-

The following table sets forth the Company’s assets that were measured at fair value as of June 30, 2015 by level within the fair value hierarchy:

	Balance as of		Fair value measurements
Description	June 30, 2015		Level 1		Level 2		Level 3

Derivative instruments asset	$	859		-	$	859		-

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)

9 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Schedule of future minimum lease commitments

Year ended June 30,	(unaudited)

2016		598
2017		2,252
2018		2,148
2019		2,003
2020 and thereafter		8,707

		15,708

STOCK CAPITAL (Tables)

9 Months Ended

Mar. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of composition of common stock capital

Authorized

Issued and outstanding

Number of shares

March 31, 2016

June 30,

2015

March 31, 2016

June 30,

2015

(unaudited)

Stock of $0.0001 par value:

Common stock

125,000,000

40,684,496

39,297,539

- Definition

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27011957&loc=d3e177068-122764

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21553-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6403732&loc=d3e21300-112643

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5

+ Details

STOCK CAPITAL (Tables)

9 Months Ended

Mar. 31, 2016

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of recognized stock-based compensation expenses

	Three months ended March 31,				Nine months ended March 31,
	2016		2015		2016		2015

Cost of revenues	$	246	$	140	$	635	$	254
Research and development		724		183		1,637		449
Selling and marketing		842		292		2,207		545
General and administrative		819		355		2,210		502

Total stock-based compensation expense	$	2,631	$	970	$	6,689	$	1,750

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of the activity in the share options

	No. of Options			Weighted average grant date fair value
Unvested as of July 1, 2015		67,440			25.09
Granted		807,656			24.45
Vested		(112,591	)		24.57
Forfeited		(40,965	)		24.07
Unvested as of March 31, 2016		721,540			24.38

Schedule of exercise price range of options

	Outstanding				Exercisable
	as of				as of
Issuance	March 31,		Exercise		March 31,		Exercisable
date	2016		price		2016		through

July 31, 2008		33,333		0.87		33,333	July 31, 2018
October 24, 2012		5,166		2.46		4,333	October 24, 2022
January 23, 2013		3,333		3.03		2,778	January 23, 2023
January 27, 2014		4,698		3.51		2,226	January 27, 2024
May 1, 2014		6,000		3.51		3,167	May 1, 2024
September 17, 2014		10,830		3.96		4,790	September 17, 2024
October 29, 2014		5,788		5.01		1,010	October 29, 2024
August 19, 2015		28,167		0.00		-
November 8, 2015		4,167		0.00		-

		101,482				51,637

Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of the activity in the share options

						Weighted
						average
				Weighted		remaining
	Number			average		contractual		Aggregate
	of			exercise		term		intrinsic
	Options			price		in years		value

Outstanding as of July 1, 2015		6,034,782			3.14		7.06		200,438
Granted		228,800			25.09
Exercised		(1,230,923	)		2.05
Forfeited or expired		(46,971	)		3.86
Outstanding as of March 31, 2016		4,985,688			4.41		6.75		103,375

Vested and expected to vest as of March 31, 2016		4,798,492			4.33		6.73		99,877

Exercisable as of March 31, 2016		3,099,118			2.88		5.65		68,974

Schedule of exercise price range of options

			Weighted		Options		Weighted
	Outstanding		average		exercisable		average
Range of	as of		remaining		as of		remaining
exercise	March 31,		contractual		March 31,		contractual
price	2016		life in years		2016		life in years

$0.87 - $1.50		770,940		2.89		770,940		2.89
$1.68 - $2.46		1,465,040		5.49		1,408,292		5.46
$3.03 - $3.96		542,018		7.53		279,270		7.24
$5.01		1,945,562		8.66		602,296		8.66
$9.36		33,328		8.84		9,720		8.84
$25.09		228,800		9.39		28,600		9.39

		4,985,688		6.75		3,099,118		5.65

INCOME TAXES (Tables)

9 Months Ended

Mar. 31, 2016

Income Tax Disclosure [Abstract]

Schedule of taxes on income

	Three months ended March 31,					Nine months ended March 31,
	2016			2015		2016			2015
	Unaudited					Unaudited

Current year taxes	$	1,069		$	398	$	2,380		$	1,146
Previous year taxes		-			-		(216	)		-
Deferred tax expense (income)		(100	)		-		(6,627	)		-

Taxes on income (tax benefit)	$	969		$	398	$	(4,463	)	$	1,146

Schedule of deferred tax liabilities and assets

	March 31,		June 30,
	2016		2015
	(Unaudited)

Assets in respect of:

Carryforward tax losses	$	-	$	23,033
Research and Development carryforward expenses- temporary differences		4,488		5,173
Stock-based compensation		548		-
Other reserves		1,450		1,346

		6,486		29,552

Valuation allowance (1)		-		(29,552	)

Net deferred tax assets	$	6,486	$	-

BASIC AND DILUTED NET EARNINGS PER SHARE (Tables)

9 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net earnings (loss) per share

	Three months ended March 31,					Nine months ended March 31,
	2016		2015			2016		2015
	(unaudited)					(unaudited)
Numerator:
Net income		20,799		5,965			59,336		11,860
Dividends accumulated for the period		-		(5,923	)		-		(11,817	)
Net income available to holders of common stock		20,799		42			59,336		43

Denominator:
Shares used in computing net earnings per share of common stock, basic		40,362,093		2,822,893			39,725,227		2,817,090

Numerator:
Net income		20,799		5,965			59,336		11,860
Dividends accumulated for the period		-		(5,872	)		-		(11,782	)
Net income available to holders of common stock		20,799		93			59,336		78

Denominator:
Shares used in computing net earnings per share of common stock, diluted		44,577,901		7,099,046			44,347,071		5,534,903

GENERAL (Details)
$ in Thousands

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Jul. 31, 2015

USD ($)

Mar. 31, 2016

USD ($)

Mar. 31, 2015

USD ($)

Mar. 31, 2016

USD ($)

item

Mar. 31, 2015

USD ($)

Jun. 30, 2015

USD ($)

Organization Consolidation and Presentation of Financial Statements [Line Items]

Number of contract manufacturers | item

Number of vendors | item

Derivative financial instruments

Notional amount of derivative contract

$ 19,547

Fair value of derivative assets current

854

Fair value of derivative liabilities current

Net derivative assets

849

$ 859

Prepaid expenses and other accounts receivable

18,613

32,645

Loss from hedging transactions recorded in general and administrative expenses

Loss from hedging transactions recorded in research and development expenses

Loss from hedging transactions recorded in sales and marketing expenses

Foreign exchange forward contracts

^[1]

849

$ 859

Changes in unrealized gains, net of tax expense

668

745

Consideration paid for patents

$ 800

Useful lives of patents

10 years

Amortization expenses

$ 21

$ 63

Accounts Payable [Member]

Organization Consolidation and Presentation of Financial Statements [Line Items]

Concentration risk (as a percent)

73.00%

79.00%

[1]	Estimated to be reclassified into earnings during 2016.

GENERAL (Changes in Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Beginning balance	$ (293)		$ (222)
Other comprehensive income (loss) before reclassifications	742		673
Losses (gains) reclassified from accumulated other comprehensive income (loss)	(32)		(34)
Net current period other comprehensive income (loss)	710	$ (102)	639	$ (202)
Ending balance	417		417
Unrealized gains (losses) on available-for-sale marketable securities [Member]
Beginning balance	(81)
Other comprehensive income (loss) before reclassifications	87		6
Losses (gains) reclassified from accumulated other comprehensive income (loss)	1		1
Net current period other comprehensive income (loss)	88		7
Ending balance	7		7
Unrealized gains (losses) on cash flow hedges [Member]
Beginning balance	75
Other comprehensive income (loss) before reclassifications	668		745
Losses (gains) reclassified from accumulated other comprehensive income (loss)	(33)		(35)
Net current period other comprehensive income (loss)	635		710
Ending balance	710		710
Unrealized gains (losses) on foreign currency translation [Member]
Beginning balance	(287)		(222)
Other comprehensive income (loss) before reclassifications	(13)		(78)
Losses (gains) reclassified from accumulated other comprehensive income (loss)
Net current period other comprehensive income (loss)	(13)		(78)
Ending balance	$ (300)		$ (300)

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

MARKETABLE SECURITIES (Details) $ in Thousands	Mar. 31, 2016 USD ($) item
Schedule of Available-for-sale Securities [Line Items]
Due in one year or less, amortized cost	$ 44,050
Due in one year or less, gross unrealized gains	21
Due in one year or less, gross unrealized losses	12
Due in one year or less, fair value	44,059
Due after one year to two years, amortized cost	43,148
Due after one year to two years, gross unrealized gains	37
Due after one year to two years, gross unrealized losses	34
Due after one year to two years, fair value	43,151
Amortized cost	87,198
Gross unrealized gains	58
Gross unrealized losses	46
Fair value	$ 87,210
Number of loss positions \| item	32
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	$ 82,183
Gross unrealized gains	55
Gross unrealized losses	36
Fair value	82,202
Governmental bonds [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	5,015
Gross unrealized gains	3
Gross unrealized losses	10
Fair value	$ 5,008

INVENTORIES (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Jun. 30, 2015
Inventory Disclosure [Abstract]
Raw materials	$ 10,639	$ 14,405
Finished goods	74,875	59,545
Inventories	$ 85,514	$ 73,950

WARRANTY OBLIGATIONS (Details) - USD ($) $ in Thousands	9 Months Ended
WARRANTY OBLIGATIONS (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Mar. 31, 2015	Jun. 30, 2015
Changes in the Company's product warranty liability
Balance, at beginning of period	$ 31,879	$ 18,181
Additions and adjustments to cost of revenues	21,250	13,456
Usage and current warranty expenses	(6,470)	(3,738)
Balance, at end of period	46,659	27,899
Less current portion	13,510	7,661	$ 9,431
Long term portion	$ 33,149	$ 20,238	$ 22,448

REVOLVING CREDIT LINE (Details) - Revolving Credit Line [Member] - USD ($) $ in Thousands		9 Months Ended
	Feb. 17, 2015	Mar. 31, 2016
Line of Credit Facility [Line Items]
Aggregate borrowings	$ 40,000
Maximum specified percentage of eligible trade receivables considered for determining maximum borrowing capacity	80.00%
Description of variable rate basis		<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">Bank Lender's prime rate</div>
Termination date	Dec. 31, 2016
Amount of liquidity need to maintain	$ 6,750
Minimum [Member]
Line of Credit Facility [Line Items]
Applicable margin (as a percent)	0.50%
Maximum [Member]
Line of Credit Facility [Line Items]
Applicable margin (as a percent)	2.00%

FAIR VALUE MEASUREMENTS (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Jun. 30, 2015
Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	$ 17,520
Money Market Funds [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	17,520
Derivative Financial Instruments, Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	849	$ 859
Derivative Financial Instruments, Assets [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	849	$ 859
Short Term Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	43,055
Short Term Corporate Debt Securities [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	43,055
Short Term Governmental Bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	1,004
Short Term Governmental Bonds [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	1,004
Long Term Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	39,147
Long Term Corporate Debt Securities [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	39,147
Long Term Governmental Bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	4,004
Long Term Governmental Bonds [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	$ 4,004

LEASE INCENTIVE OBLIGATION (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Jun. 30, 2015
Leases [Abstract]
Operating lease receivable	$ 2,938
Received in cash from the Lessor	2,917
Lease incentive obligation	$ 2,265	$ 2,385

COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Future Minimum Lease Commitments) (Details) $ in Thousands	Mar. 31, 2016 USD ($)
Future minimum lease commitments
2016	$ 598
2017	2,252
2018	2,148
2019	2,003
2020 and thereafter	8,707
Future minimum lease commitments amount	$ 15,708

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Lease commitments) (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Lease commitments
Contract term	10 years
Rent expenses	$ 1,653	$ 1,222

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Guarantees) (Details) $ in Thousands	Mar. 31, 2016 USD ($)
Office Rent Lease Agreements [Member]
Guarantor Obligations [Line Items]
Guarantees amount	$ 631
Customs Transactions [Member]
Guarantor Obligations [Line Items]
Guarantees amount	53
Credit Card Limits [Member]
Guarantor Obligations [Line Items]
Guarantees amount	$ 85

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Royalty, Governmental, and Contractual purchase obligations) (Details) $ in Thousands	Mar. 31, 2016 USD ($)
Royalty commitments
Aggregate contingent liability to the BIRD-F amount	$ 1,132
Governmental commitments
Governmental commitments amount	782
Contractual purchase obligations
Non-cancelable purchase obligations	84,275
Provision for contractual inventory purchase obligations	$ 1,860

STOCK CAPITAL (Common Stock) (Details)	9 Months Ended
STOCK CAPITAL (Common Stock) (Details)	Mar. 31, 2016 $ / shares shares	Jun. 30, 2015 $ / shares shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Reverse stock split ratio	0.33
Common stock capital
Par value \| $ / shares	$ 0.0001	$ 0.0001
Authorized	125,000,000	125,000,000
Common stock, issued shares	40,684,496	39,297,539
Common stock, outstanding shares	40,684,496	39,297,539

STOCK CAPITAL (Stock option plans) (Details) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended
	Dec. 31, 2014	Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of options exercised		$ 27,602
Unrecognized compensation expense		$ 26,384
2007 Plan, Transferred to 2015 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options are available for future grant under the plan		379,358
2015 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options reserved for issuance under the plan		3,827,117
Percentage of common shares increase automatically in each year		5.00%
2015 Plan [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of common shares increase automatically in each year	5.00%
Option [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options are available for future grant under the plan		10,000,000
Employee Stock Purchase Plan [Member] \| 2015 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options are available for future grant under the plan		2,731,852
Options And RSUs [Member] \| Employees and Members of Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair values options granted to employees and executive directors		$ 25.09
Restricted Stock Units (RSUs) [Member] \| Employees and Members of Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair values options granted to employees and executive directors		$ 24.45

STOCK CAPITAL (Summary of activity in the share options) (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Mar. 31, 2016	Jun. 30, 2015
Aggregate intrinsic Value
Exercised	$ 27,602
Option [Member] \| Employees and Members of Board of Directors [Member]
Number of options
Outstanding as of July 1, 2015	6,034,782
Granted	228,800
Exercised	(1,230,923)
Forfeited or expired	46,971
Outstanding as of March 31, 2016	4,985,688	6,034,782
Weighted average exercise price
Outstanding as of July 1, 2015	$ 3.14
Granted	25.09
Exercised	2.05
Forfeited or expired	3.86
Outstanding as of March 31, 2016	$ 4.41	$ 3.14
Weighted average remaining contractual term in years
Outstanding	6 years 9 months	7 years 22 days
Aggregate intrinsic Value
Outstanding as of July 1, 2015	$ 200,438
Outstanding as of March 31, 2016	$ 103,375	$ 200,438
Vested and expected to vest at the end of the period
Number of options	4,798,492
Weighted average exercise price	$ 4.33
Weighted average remaining contractual term in years	6 years 8 months 23 days
Aggregate intrinsic Value	$ 99,877
Exercisable as of March 31, 2016
Weighted average exercise price	$ 2.88
Weighted average remaining contractual term in years	5 years 7 months 24 days
Aggregate intrinsic Value	$ 68,974

STOCK CAPITAL (Schedule of exercise price ranges) (Details) - Employees and Members of Board of Directors [Member]	9 Months Ended
	Mar. 31, 2016 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding	4,985,688
Weighted average remaining contractual Life in years	6 years 9 months
Exercisable	3,099,118
Weighted average remaining contractual Life in years	5 years 7 months 24 days
$0.50 - $1.50 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower \| $ / shares	$ 0.87
Range of exercise price, upper \| $ / shares	$ 1.50
Outstanding	770,940
Weighted average remaining contractual Life in years	2 years 10 months 21 days
Exercisable	770,940
Weighted average remaining contractual Life in years	2 years 10 months 21 days
$1.68 - $2.46 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower \| $ / shares	$ 1.68
Range of exercise price, upper \| $ / shares	$ 2.46
Outstanding	1,465,040
Weighted average remaining contractual Life in years	5 years 5 months 27 days
Exercisable	1,408,292
Weighted average remaining contractual Life in years	5 years 5 months 16 days
$3.03 - $3.96 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price, lower \| $ / shares	$ 3.03
Range of exercise price, upper \| $ / shares	$ 3.96
Outstanding	542,018
Weighted average remaining contractual Life in years	7 years 6 months 11 days
Exercisable	279,270
Weighted average remaining contractual Life in years	7 years 2 months 27 days
$5.01 - $5.04 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price \| $ / shares	$ 5.01
Outstanding	1,945,562
Weighted average remaining contractual Life in years	8 years 7 months 28 days
Exercisable	602,296
Weighted average remaining contractual Life in years	8 years 7 months 28 days
$9.36 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price \| $ / shares	$ 9.36
Outstanding	33,328
Weighted average remaining contractual Life in years	8 years 10 months 2 days
Exercisable	9,720
Weighted average remaining contractual Life in years	8 years 10 months 2 days
$25.09 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price \| $ / shares	$ 25.09
Outstanding	228,800
Weighted average remaining contractual Life in years	9 years 4 months 21 days
Exercisable	28,600
Weighted average remaining contractual Life in years	9 years 4 months 21 days

STOCK CAPITAL (Summary of the activity in the RSUs) (Details) - Restricted Stock Units (RSUs) [Member] - Employees and Members of Board of Directors [Member]	9 Months Ended
	Mar. 31, 2016 $ / shares shares
No. of Options
Unvested as of July 1, 2015 \| shares	67,440
Granted \| shares	807,656
Vested \| shares	(112,591)
Forfeited \| shares	(40,965)
Unvested as of March 31, 2016 \| shares	721,540
Weighted average grant date fair value
Unvested as of July 1, 2015 \| $ / shares	$ 25.09
Granted \| $ / shares	24.45
Vested \| $ / shares	24.57
Forfeited \| $ / shares	24.07
Unvested as of March 31, 2016 \| $ / shares	$ 24.38

STOCK CAPITAL (Options and RSUs issued to non-employee consultants) (Details) - Options And RSUs [Member] - Nonemployee Consultants [Member]	Mar. 31, 2016 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	101,482
Exercisable at the end of the period	51,637
July 31, 2008 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	33,333
Exercise price \| $ / shares	$ 0.87
Exercisable at the end of the period	33,333
October 24, 2012 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	5,166
Exercise price \| $ / shares	$ 2.46
Exercisable at the end of the period	4,333
January 23, 2013 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	3,333
Exercise price \| $ / shares	$ 3.03
Exercisable at the end of the period	2,778
January 27, 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	4,698
Exercise price \| $ / shares	$ 3.51
Exercisable at the end of the period	2,226
May 1, 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	6,000
Exercise price \| $ / shares	$ 3.51
Exercisable at the end of the period	3,167
September 17, 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	10,830
Exercise price \| $ / shares	$ 3.96
Exercisable at the end of the period	4,790
October 29, 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	5,788
Exercise price \| $ / shares	$ 5.01
Exercisable at the end of the period	1,010
August 19, 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	28,167
Exercise price \| $ / shares	$ 0.00
Exercisable at the end of the period
November 8, 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at the end of the period	4,167
Exercise price \| $ / shares	$ 0.00
Exercisable at the end of the period

STOCK CAPITAL (Schedule of stock-based compensation expense for employees and consultants) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 2,631	$ 970	$ 6,689	$ 1,750
Nonemployee Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	91	228	464	331
Cost of revenues [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	246	140	635	254
Research and development [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	724	183	1,637	449
Selling and marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	842	292	2,207	545
General and administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 819	$ 355	$ 2,210	$ 502

INCOME TAXES (Schedule of Taxes on Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Current year taxes	$ 1,069	$ 398	$ 2,380	$ 1,146
Previous year taxes			(216)
Deferred tax expense (income)	(100)		(6,627)
Taxes on income (tax benefit)	$ 969	$ 398	$ (4,463)	$ 1,146

INCOME TAXES (Schedule of Deferred Tax Liabilities And Assets) (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Jun. 30, 2015
Assets in respect of:
Carryforward tax losses		$ 23,033
Research and Development carryforward expenses- temporary differences	4,488	5,173
Stock-based compensation	548
Other reserves	1,450	1,346
Deferred tax assets, gross	6,486	29,552
Valuation allowance		(29,552)
Net deferred tax assets	$ 6,486

BASIC AND DILUTED NET EARNINGS PER SHARE (Narrative) (Details) - shares	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Earnings Per Share [Abstract]
Total weighted average number of shares related to the outstanding stock options, convertible preferred stock and warrants to purchase convertible preferred stock and common stock, excluded from the calculation of diluted net earnings (loss) per share due to their anti-dilutive effect	0	28,351,707	12,945	27,378,784

BASIC AND DILUTED NET EARNINGS PER SHARE (Schedule of Computation of Basic and Diluted Net Earnings (Loss) Per Share) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Numerator:
Net income	$ 20,799	$ 5,965	$ 59,336	$ 11,860
Dividends accumulated for the period		(5,923)		(11,817)
Net income available to holders of common stock	$ 20,799	$ 42	$ 59,336	$ 43
Denominator:
Shares used in computing net earnings (loss) per share of common stock, basic (in shares)	40,362,093	2,822,893	39,725,227	2,817,090
Numerator:
Net income	$ 20,799	$ 5,965	$ 59,336	$ 11,860
Dividends accumulated for the period		(5,872)		(11,782)
Net income available to holders of common stock	$ 20,799	$ 93	$ 59,336	$ 78
Denominator:
Shares used in computing net earnings per share of common stock, diluted	44,577,901	7,099,046	44,347,071	5,534,903

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS (Details)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2016	Jun. 30, 2015
Revenues [Member] \| Customer One [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)	26.70%	34.90%
Revenues [Member] \| Customer Two [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)	26.70%	34.90%
Revenues [Member] \| Customer Three [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)	26.70%
Revenues [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)			24.60%
Accounts Receivable [Member] \| Customer One [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)		38.50%
Accounts Receivable [Member] \| Customer Two [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)		38.50%
Accounts Receivable [Member] \| Customer Three [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)		38.50%
Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)			30.00%